Cantel Medical Expands its Direct Sales Operations in Canada through the Acquisition of its Endoscopy Assets from Vantage Endoscopy

Monday, September 26, 2016 General News
Email Print This Page Comment bookmark
Font : A-A+

LITTLE FALLS, N.J., Sept. 26, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), a leading global company dedicated

to delivering innovative infection prevention products and services, today announced that the Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian
distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd. The endoscope reprocessing business consists of Cantel's MedivatorsŪ-branded automated endoscope reprocessors, chemistries, consumables and a full sales and service organization.

Jorgen B. Hansen, President and CEO of Cantel Medical said, "This acquisition is consistent with Cantel's strategy to expand its products and services into key markets to provide global solutions that meet local needs. We are pleased to be able to offer customers an expanded MedivatorsŪ-branded product portfolio while providing the same level of high-quality service and support they have always received. We look forward to continuing these relationships and partnering with them in the future."

"The expansion of our commercial platform and the addition of a direct sales and service organization for our Endoscopy business will further strengthen Cantel's share in the infection prevention market in Canada." stated Michael Spicer, President, Americas Sales, UK, Canada, Latin America and Global Service. "Expanding our presence in the Canadian market will enable us to realize the full potential of our portfolio while also enabling us to offer a broader suite of infection prevention products from all Cantel divisions."

About Cantel Medical

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.

To view the original version on PR Newswire, visit:

SOURCE Cantel Medical Corp.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store